Scarica l'app Stockscreener
10.10
3.80%
0.37
Dopo l'orario di chiusura:
9.60
-0.50
-4.95%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ETNB Giù?
Forum
Previsione
Precedente Chiudi:
$9.73
Aprire:
$9.56
Volume 24 ore:
2.04M
Relative Volume:
0.98
Capitalizzazione di mercato:
$1.50B
Reddito:
-
Utile/perdita netta:
$-174.61M
Rapporto P/E:
-5.1269
EPS:
-1.97
Flusso di cassa netto:
$-165.54M
1 W Prestazione:
+3.48%
1M Prestazione:
-0.10%
6M Prestazione:
+26.57%
1 anno Prestazione:
+32.89%
Intervallo 1D:
$9.56
$10.34
Intervallo di 1 settimana:
$9.45
$10.34
Portata 52W:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Nome
89 Bio Inc
Settore
Industria
Telefono
(415) 432-9270
Indirizzo
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Confronta ETNB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
10.10 | 1.50B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-14 | Iniziato | Goldman | Neutral |
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-04-22 | Ripresa | BofA Securities | Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-08-28 | Iniziato | UBS | Buy |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2022-05-12 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-26 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Ripresa | BTIG Research | Buy |
| 2021-05-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Iniziato | Raymond James | Strong Buy |
| 2020-09-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-31 | Iniziato | Piper Sandler | Overweight |
| 2020-07-23 | Iniziato | BTIG Research | Buy |
| 2020-07-07 | Iniziato | Chardan Capital Markets | Buy |
| 2019-12-09 | Iniziato | BofA/Merrill | Neutral |
| 2019-12-09 | Iniziato | Oppenheimer | Outperform |
| 2019-12-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-12-09 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
89 Bio Inc Borsa (ETNB) Ultime notizie
89bio Inc (ETNB Stock: A Sea of Opportunity - investchronicle.com
Assenagon Asset Management S.A. Increases Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
California State Teachers Retirement System Increases Stock Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Cantor Fitzgerald Estimates 89bio FY2026 Earnings - Defense World
Transcript : 89bio, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 11 - MarketScreener
89bio, Inc. (NASDAQ:ETNB) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Ameriprise Financial Inc. Has $221,000 Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89Bio Announces Inducement Grants Under Nasdaq Listing Rule - marketscreener.com
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News - GuruFocus
89bio Expands Team with 61,100 Share Options Grant to Key New Hires - Stock Titan
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
89bio Showcases Liver Disease Pipeline at Goldman Sachs Healthcare Conference Next Week - Stock Titan
Nuveen Asset Management LLC Sells 3,420 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Two Sigma Investments LP Sells 131,167 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Bought by Bank of America Corp DE - Defense World
ProShare Advisors LLC Raises Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Holdings Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
89bio holds annual meeting, directors elected By Investing.com - Investing.com Canada
89bio Elects Directors and Approves Proposals at Annual Meeting - TipRanks
89bio holds annual meeting, directors elected - Investing.com
89bio Inc (NASDAQ: ETNB) Is A Blank Check For Growth - Stocksregister
Deutsche Bank AG Has $610,000 Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Millennium Management LLC Has $5.54 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (ETNB) Price Target Slightly Reduced by BofA, Buy Rating M - GuruFocus
89bio (ETNB) Price Target Slightly Reduced by BofA, Buy Rating Maintained | ETNB Stock News - GuruFocus
89bio price target lowered to $30 from $31 at BofA - TipRanks
89bio, Inc. (ETNB) Stock Analysis: Exploring the 210% Upside Potential in Biotech - DirectorsTalk Interviews
89bio’s (ETNB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
Is 89bio (NASDAQ:ETNB) A Risky Investment? - simplywall.st
Northern Trust Corp Increases Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
BNP Paribas Financial Markets Takes Position in 89bio, Inc. (NASDAQ:ETNB) - The AM Reporter
Will Other Major MASH Deals Follow GSK/Boston Pharma? - insights.citeline.com
Dimensional Fund Advisors LP Buys New Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Stock Holdings Increased by Price T Rowe Associates Inc. MD - Defense World
Voya Investment Management LLC Sells 1,476 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Why 89bio, Inc. (ETNB) Is Among the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance
Hsbc Holdings PLC Invests $87,000 in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Weiss Ratings Reaffirms “Sell (D-)” Rating for 89bio (NASDAQ:ETNB) - Defense World
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
89bio, Inc. (NASDAQ:ETNB) Receives $27.25 Consensus Target Price from Analysts - Defense World
Deeper Dive: Understanding 89bio Inc (ETNB) Through its Various Ratios - DWinneX
MetLife Investment Management LLC Raises Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio to Participate in Upcoming Investor Conferences - The Manila Times
89bio Schedules Double Fireside Chats: Key Updates Coming at Major Healthcare Conferences - Stock Titan
89bio Inc. Reports Q1 2025 Financial Results - TipRanks
Invesco Ltd. Acquires 3,893 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Wells Fargo & Company MN Has $394,000 Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Brokers Offer Predictions for 89bio FY2025 Earnings - Defense World
Decoding 89bio Inc (ETNB): A Strategic SWOT Insight - GuruFocus
89 Bio Inc Azioni (ETNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):